BBP - Virtus Biotech ETF
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
As of Jun 30, 2026: spot at $96.98, ATM IV 26.5%, max pain $77.00, net GEX -$322.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $38.8M
- Beta
- 0.79
- 52-Week Range
- 58.04-95.53
- IPO Date
- Dec 17, 2014
- Exchange
- AMEX
What BBP Looks Like to Options Traders Today
IV rank of 27.1% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$322) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (-0.018) is roughly flat across the wings.
What This Page Covers
The BBP overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked BBP overview questions
- What is BBP?
- BBP is the ticker symbol for Virtus Biotech ETF, an listed exchange-traded fund. The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Listed on AMEX. BBP is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the BBP options snapshot look like today?
- As of Jun 30, 2026, the BBP options snapshot shows spot at $96.98, ATM IV 26.5%, IV rank 27.1%, max pain $77.00, net GEX -$322, expected move 7.60%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are BBP's key statistics?
- Virtus Biotech ETF (BBP) carries a market capitalization of $38.8M, 52-week range of 58.04-95.53. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does BBP belong to?
- Virtus Biotech ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare BBP's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the BBP data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.